Five Prime Therapeutics
Earnings Date & Report
Last updated:
Five Prime Therapeutics’s last earnings date was on 22 Mar 2021. It reported its quarterly earnings per share (EPS) reaching -$0.51, beating the estimated value of -$0.52 by $0.01. The company’s quarterly earnings decreased by 122.06% to -708K US dollars compared to the same quarter of the previous year. Over the last year, Five Prime Therapeutics’s earnings per share have grown by 42.7%.
Five Prime Therapeutics stock Earnings report, Estimates & History
| 2016-05-05 | -0.71 | -0.49 |
|---|---|---|
| 2016-08-04 | -0.56 | -0.49 |
| 2016-11-03 | -0.51 | -0.72 |
| 2017-02-23 | -0.57 | -0.73 |
| 2017-05-04 | -1.02 | -1.21 |
| 2017-08-08 | -1.21 | -1.58 |
| 2017-11-06 | -1.24 | -1.54 |
| 2018-02-27 | -1.31 | -1.04 |
| 2018-05-08 | -0.55 | -0.63 |
| 2018-08-08 | -1.29 | -0.99 |
| 2018-11-06 | -1.15 | -1.37 |
| 2019-02-26 | -1.32 | -1.12 |
| 2019-05-08 | -1.06 | -1.02 |
| 2019-08-07 | -0.9 | -0.99 |
| 2019-11-06 | -0.95 | -1.03 |
| 2020-02-27 | -0.96 | -0.89 |
| 2020-05-07 | -0.67 | -0.57 |
| 2020-08-06 | -0.69 | -0.48 |
| 2020-11-03 | -0.6 | -0.74 |
| 2021-03-22 | -0.52 | -0.51 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Five Prime Therapeutics stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 22 Mar 2021 | Beat | -$0.52 | -$0.51 | N/A | -708K | |
| 3 Nov 2020 | Missed | -$0.6 | -$0.74 | 1.66M | 2.04M | Earnings Call Transcript |
| 6 Aug 2020 | Beat | -$0.69 | -$0.48 | 4.92M | 3.42M | |
| 7 May 2020 | Beat | -$0.67 | -$0.57 | 9.89M | 8.41M | |
| 27 Feb 2020 | Beat | -$0.96 | -$0.89 | 3.46M | 3.21M | Earnings Call Transcript |
| 6 Nov 2019 | Missed | -$0.95 | -$1.03 | 2.75M | 2.98M | Earnings Call Transcript |
| 7 Aug 2019 | Missed | -$0.9 | -$0.99 | 3.03M | 3.33M | |
| 8 May 2019 | Beat | -$1.06 | -$1.02 | 5.55M | 5.34M | |
| 26 Feb 2019 | Beat | -$1.32 | -$1.12 | 4.75M | 4.03M | Earnings Call Transcript |
| 6 Nov 2018 | Missed | -$1.15 | -$1.37 | 4.84M | 5.77M | Earnings Call Transcript |
| 8 Aug 2018 | Beat | -$1.29 | -$0.99 | 9.87M | 7.58M | Earnings Call Transcript |
| 8 May 2018 | Missed | -$0.55 | -$0.63 | 28.36M | 32.48M | |
| 27 Feb 2018 | Beat | -$1.31 | -$1.04 | 16.64M | 13.21M | Earnings Call Transcript |
| 6 Nov 2017 | Missed | -$1.24 | -$1.54 | 6.70M | 8.33M | Earnings Call Transcript |
| 8 Aug 2017 | Missed | -$1.21 | -$1.58 | 5.99M | 7.82M | Earnings Call Transcript |
| 4 May 2017 | Missed | -$1.02 | -$1.21 | 8.54M | 10.13M | Earnings Call Transcript |
| 23 Feb 2017 | Missed | -$0.57 | -$0.73 | 6.45M | 8.26M | Earnings Call Transcript |
| 3 Nov 2016 | Missed | -$0.51 | -$0.72 | 4.73M | 6.68M | Earnings Call Transcript |
| 4 Aug 2016 | Beat | -$0.56 | -$0.49 | 10.54M | 9.22M | Earnings Call Transcript |
| 5 May 2016 | Beat | -$0.71 | -$0.49 | 9.44M | 6.52M | |
Five Prime Therapeutics Earnings report FAQs
When is Five Prime Therapeutics's next Earnings date?
The company has not set the next earnings date yet. The latest Five Prime Therapeutics's earnings date was on 27 Feb 2020.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.